Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 5/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | XIAP | P98170 | 1/20 | 0.55 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | NOS3 | P29474 | 3/20 | 0.49 |
| ▸ | NOS1 | P29475 | 3/20 | 0.49 |
| ▸ | NOS2 | P35228 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| M-Fluorophenylalanine SCHEMBL18096561 | 0.89 | PTPN1 (0.50) | PTPN1SLC1A1SLC7A5ALPIPKM | |
| M-Fluorophenylalanine SCHEMBL18096562 | 0.89 | PTPN1 (0.50) | PTPN1SLC1A1SLC7A5ALPIPKM | |
| M-Fluorophenylalanine SCHEMBL29424682 | 0.89 | SLC1A1 (0.69) | SLC1A1SLC7A5ALPIPKMPTGS1 | |
| M-Fluorophenylalanine SCHEMBL42949 | 0.89 | SLC1A1 (0.69) | SLC1A1SLC7A5ALPIPKMPTGS1 | |
| M-Fluorophenylalanine SCHEMBL288728 | 0.89 | SLC1A1 (0.69) | SLC1A1SLC7A5ALPIPKMPTGS1 | |
| M-Fluorophenylalanine SCHEMBL29580111 | 0.89 | SLC1A1 (0.69) | SLC1A1SLC7A5ALPIPKMPTGS1 | |
| M-Fluorophenylalanine SCHEMBL42948 | 0.89 | SLC1A1 (0.69) | SLC1A1SLC7A5ALPIPKMPTGS1 | |
| M-Fluorophenylalanine SCHEMBL21057063 | 0.87 | SLC1A1 (0.68) | SLC1A1SLC7A5ALPIPKMPTGS1 | |
| M-Fluorophenylalanine SCHEMBL27547062 | 0.87 | SLC1A1 (0.68) | SLC1A1SLC7A5ALPIPKMPTGS1 | |
| M-Fluorophenylalanine SCHEMBL21057062 | 0.87 | SLC1A1 (0.68) | SLC1A1SLC7A5ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10894954-B2 | Subtilisin variants and uses thereof | UVIC IND PARTNERSHIPS INC (CA) | 2021-01-19 | — | — | US | disclosed |
| US-20200071687-A1 | SUBTILISIN VARIANTS AND USES THEREOF | UVIC INDUSTRY PARTNERSHIPS INC. (CA) | 2020-03-05 | — | — | US | disclosed |
| US-20180201916-A1 | VARIANTS OF THE SUBTILISIN CARLSBERG POLYPEPTIDE WITH DECREASED THERMOSTABILITY | UVIC INDUSTRY PARTNERSHIPS INC. (CA) | 2018-07-19 | — | — | US | disclosed |
| WO-2017006266-A9 | VARIANTS OF THE SUBTILISIN CARLSBERG POLYPEPTIDE WITH DECREASED THERMOSTABILITY | DENOVO GENOMICS, INC. (CA) | 2017-03-16 | — | — | WO | disclosed |
| WO-2017006266-A1 | VARIANTS OF THE SUBTILISIN CARLSBERG POLYPEPTIDE WITH DECREASED THERMOSTABILITY | DENOVO GENOMICS, INC. (CA) | 2017-01-12 | — | — | WO | disclosed |
| US-9486472-B2 | Methods for modulating neuronal responses | UNIVERSITY OF BRITISH COLUMBIA CANADA (CA) | 2016-11-08 | — | — | US | disclosed |
| EP-1687427-B1 | METHODS FOR MODULATING NEURONAL RESPONSES | UNIV BRITISH COLUMBIA (CA) | 2016-08-24 | — | — | EP | disclosed |
| US-20160045588-A1 | CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2016-02-18 | — | — | US | disclosed |
| US-20150175985-A1 | Enhancing Vegetative Protein Production in Transgenic Plants Using Seed Specific Promoters | KERMODE, ALLISON R. (CA) | 2015-06-25 | — | — | US | disclosed |
| US-8956824-B2 | Methods for identifying allosteric modulators of ship polypeptides | BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) | 2015-02-17 | — | — | US | disclosed |
| WO-2004096842-A2 | SARS VIRUS NUCLEOTIDE AND AMINO ACID SEQUENCES AND USES THEREOF | PUBLIC HEALTH AGENCY OF CANADA (CA) | 2004-11-11 | — | — | WO | disclosed |
| US-20040110676-A1 | Methods for modulating cell survival | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2004-06-10 | — | — | US | disclosed |
| WO-2004037281-A1 | METHODS FOR NEUROPROTECTION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2004-05-06 | — | — | WO | disclosed |
| WO-2004026895-A2 | GD2 LIGANDS | MCGILL UNIVERSITY (CA) | 2004-04-01 | — | — | WO | disclosed |
| WO-2004024759-A1 | METHODS AND REAGENTS FOR MODULATING CELL PROLIFERATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2004-03-25 | — | — | WO | disclosed |
| EP-1399740-A2 | TYPE 1 DIABETES DIAGNOSTICS AND THERAPEUTICS | The University of British Columbia (CA) | 2004-03-24 | — | — | EP | disclosed |
| US-20030212001-A1 | Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions | THERATECHNOLOGIES INC. (CA) | 2003-11-13 | — | — | US | disclosed |
| WO-2003080659-A1 | METHODS AND COMPOUNDS FOR PREVENTION AND TREATMENT OF ELEVATED INTRAOCULAR PRESSURE AND RELATED CONDITIONS | THERATECHNOLOGIES INC. (CA) | 2003-10-02 | — | — | WO | disclosed |
| WO-2003076621-A2 | VPR MODULATORS AND USES THEREOF | UNIVERSITE DE MONTREAL (CA) | 2003-09-18 | — | — | WO | disclosed |
| WO-2003001204-A2 | TYPE 1 DIABETES DIAGNOSTICS AND THERAPEUTICS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2003-01-03 | — | — | WO | disclosed |